Elevara Medicines is a startup based in the United Kingdom, most recent round Series A, 1 tracked investor.
Elevara Medicines is a company founded in 2023 headquartered in the United Kingdom. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Elevara Medicines is a clinical-stage biotech company focused on developing therapies for rheumatoid arthritis and chronic inflammatory diseases, specifically targeting fibroblast-like synoviocytes to overcome the limitations of existing immunosuppressive treatments.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.